Literature DB >> 29546950

[Acute Cerebrovascular events associated to hemolytic uremic syndrome: Description of two pediatric cases].

M López1, I Huete2, Marta Hernández1.   

Abstract

Diarrhea-associated Hemolytic Uremic Syndrome (D+HUS) is a multisystem disorder in which neurological involvement (35 to 50%) is associated to adverse outcome. An important cause of a permanent neurological impairment is the cerebrovascular pathology.
OBJECTIVE: To report two pediatric cases of D+HUS with severe neurological involvement due to cerebrovascular disease, and review available literature. CLINICAL CASES: Two previously healthy 15- and 21-month-old children debuted with seizures and impairment of consciousness within the first week of a D+HUS. Both presented hypertension, severe acute renal failure, and focal motor deficit. One child showed significant improvement in neurologic status after five sessions of plasmapheresis. Brain magnetic resonance showed in the first child multiple bilateral infarcts of small vessels and lesions of white matter. In the second patient, large bilateral infarcts on both middle cerebral arteries territories were identified. One year after the acute event, both children showed functional impairment; The first patient evolved with language delay and spastic hemiparesis; the second patient with spastic quadriparesis, epilepsy with poor seizure control and marked functional impairment.
CONCLUSION: Although most of the children with D+HUS and brain involvement do not have long-term sequelae, cerebrovascular disease in the acute period causes permanent damage, and in addition to the management of electrolyte disturbances, hypertension, and renal failure, therapies directed at specific pathophysiological mechanisms that trigger vascular compromise may improve prognosis.

Entities:  

Mesh:

Year:  2017        PMID: 29546950     DOI: 10.4067/S0370-41062017000500011

Source DB:  PubMed          Journal:  Rev Chil Pediatr        ISSN: 0370-4106


  2 in total

1.  Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli.

Authors:  Jorge Goldstein; Krista Nuñez-Goluboay; Alipio Pinto
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

2.  Increased history of ischemic stroke and decreased neurocognitive performance in children with chronic kidney disease.

Authors:  Juan C Kupferman; Matthew B Matheson; Marc B Lande; Joseph T Flynn; Susan Furth; Bradley A Warady; Stephen R Hooper
Journal:  Pediatr Nephrol       Date:  2020-02-24       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.